Posts from ‘December, 2009’

Protects Firefighters and Civilians from a Silent Mind boggling CHELMSFORD, Mass.–(HSMN NewsFeed)–ZOLL Clinical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. …
Devices, Monitoring, FDA
ZOLL Medical, carbon monoxide, Masimo, CO-Oximetry, defibrillator

RARITAN, N.J., Dec. 30 (HSMN NewsFeed) — Johnson & Johnson Medical Research & Development, L.L.C. (J&JPRD) today announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Appl…
Biopharmaceuticals, FDA
J&JPRD, ceftobiprole, cSSSI, Basilea Pharmaceutica

MOUNTAINSIDE, NJ - (HSMN NewsFeed) - Proteonomix, Inc. (Pinksheets:PROT ) announces that Joel Pensley has resigned as secretary, director and general counsel and Roger Fidler has joined the Company as director and general counsel; and Steven Byle, presentl…
Biopharmaceuticals, Personnel
Proteonomix

MINNEAPOLIS, Dec. 28, 2009 –(HSMN NewsFeed) — Vascular Solutions, Inc. (Nasdaq:VASC ) announced that the First Circuit of the U.S. Court of Appeals has affirmed the judgment in its favor in its product disparagement litigation with Marine Polymer Technol…
Devices, Litigation
Vascular Solutions, Marine Polymer Technologies, D-Stat, D-Stat Dry, hemostat

ORLANDO, Fla., Dec. 28 (HSMN NewsFeed) — GeneLink BioSciences, Inc., (OTC Bulletin Board: GNLK) a big consumer genomics and biotechnology company (www.genelinkbio.com), is pleased to announce the appointment of David L. Macdonald as its interim Chie…
Personalized Medicine, Personnel
GeneLink BioSciences, GeneWize Life Sciences, LifeMap Me

December 24th Open House Showcases the Addition of a New Building to the Corporate Campus and New Health Care & Wellness Plan For Masimo Employees IRVINE, Calif., Dec. 24 (HSMN NewsFeed) — Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) …
Devices, Monitoring
Masimo, Rainbow SET, Pulse Oximetry, Pulse Oximeter

UNION CITY, Calif., Dec. 24, 2009 –(HSMN NewsFeed) - Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR ) today announced the U.S. Food & Drug Administration (FDA) now considers that Questcor has provided a complete response to all prior action letters for its s…
Biopharmaceuticals, FDA
Questcor Pharmaceuticals, Acthar, corticotropin

The Transaction Promotes the Strategic Goals of Teva-KOWA Pharma JERUSALEM–(HSMN NewsFeed)–Teva Medical Industries Ltd. (NASDAQ: TEVA ) announced today that Teva-KOWA Pharmaceutical Co., Ltd., the Company’s joint venture in Japan with KOWA Company, Ltd…
Biopharmaceuticals, Mergers & Acquisitions
Teva Clinical, Teva-KOWA Pharma, Taisho Lab

NATICK, Mass., Dec. 23 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement with the U.S. Department of Justice regarding the Department’s investigation relating to certain post-market s…
Devices, Cardiology
Boston Scientific, Guidant

Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY), Kowa Company, …
Biopharmaceuticals, Cardiology, Licensing
Eli Lilly, Kowa Pharmaceuticals, LIVALO, pitavastatin, hyperlipidemia